山西省科技厅,面上项目,基于PI3K/AKT通路研究雷公藤红素对索拉非尼治疗原发性肝癌的提效和降低耐药性的作用及其分子机制,8万,2022.1-2024.12,在研,主持。
山西省卫健委,一般项目,基于PI3K/AKT通路研究雷公藤红素对原发性肝癌的治疗作用,3万,2021.6-2023.6,在研,主持。
国家自然科学基金,面上项目circRNA0007766/miR4492/MET/ PI3K-Akt通路调控食管胃结合部腺癌增殖和侵袭的分子机制研究,55万,在研,参加。
代表性论著及近五年的代表性论文(限10项以内):
Zhang R, Zhang HZ, Han T, Wei ZG, Shi ZY, Xu J. Effect of accessory hepatic artery reconstruction on prognosis in orthotopic liver transplantation: a single center experience. BMC Surg. 2023 May 19;23(1):138.
Rui Zhang, Zhi-Jun Zhu, Li-Ying Sun, Lin Wei, Wei Qu. Outcomes of Liver Transplantation Using Pediatric Deceased Donor Livers: A Single‑Center Analysis of 102 Donors. Chinese Medical Journal, 2018, 131(6): 677-683.
R. Zhang, Z.-J. Zhu, L.-Y. Sun, L. Wei, W. Qu, Z.-G. Zeng, and Y. Liu. Outcomes of Pediatric Liver Transplantation: Deceased Donor Liver Transplantation vs Living Donor Liver Transplantation. Transplantation Proceedings, 2018, 50: 3601-3605.
Rui Zhang, Zhi-Jun Zhu, Li-Ying Sun. Application of Pediatric Donor Livers After Circulatory Death in Adult Liver Transplantation: A Single-Center Experience. Experimental and Clinical Transplantation, 2018, 5: 575-581.
Rui Zhang, Zhi Chen, Shu-Sheng Wu, Jun Xu, Ling-Chun Kong, Pei Wei, Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib. Med Sci Monit, 2019, 25: 4068-4075.
张瑞, 陈智, 武书胜, 徐钧. 和厚朴酚抑制糖酵解增强索拉菲尼抗肝癌细胞活性. 中华实验外科杂志, 2018, 35(1): 72-74.
张瑞, 徐钧, 董永红, 陈智, 武书胜. 腹腔镜远端胃癌D2根治术后并发症及其防治. 中国临床研究, 2017, 30(5): 679-681.
张瑞, 徐钧, 陈智, 武书胜, 董永红. 腹腔镜肝切除治疗肝脏占位性病变的临床研究. 山西医科大学学报, 2017, 48(1): 69-71.
张瑞, 武书胜, 徐钧, 陈智, 底卫东. 双镜联合治疗胆囊结石胆总管结石的临床应用. 中国药物与临床, 2015, 15(12): 1749-1750.